REQUEST A DEMO
Total
USD $0.00
Search more companies

Unidad De Tratamiento Del Dolor Caribe S.A.S. (Colombia)

Main Activities: Ambulatory Health Care Services
Full name: Unidad De Tratamiento Del Dolor Caribe S.A.S. Profile Updated: September 25, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Unidad De Tratamiento Del Dolor Caribe S.A.S. is an enterprise in Colombia, with the main office in Valledupar. The enterprise currently operates in the Ambulatory Health Care Services sector. The company was established on November 13, 2019. From the latest financial highlights, Unidad De Tratamiento Del Dolor Caribe S.A.S. reported a net sales revenue increase of 194.29% in 2023. Its’ total assets recorded a growth of 37.25%. In, 2023, the company’s net profit margin increased by 23.29%.

Headquarters
Calle 16 Nro. 19 D - 28 Consultorio 409
Valledupar; Cesar;

Contact Details: Purchase the Unidad De Tratamiento Del Dolor Caribe S.A.S. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Unidad De Tratamiento Del Dolor Caribe S.A.S. report to view the information.
Incorporation Date:
November 13, 2019
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Unidad De Tratamiento Del Dolor Caribe S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
194.29%
Total operating revenue
194.29%
Operating profit (EBIT)
1758.75%
Net Profit (Loss) for the Period
2253.03%
Total assets
37.25%
Total equity
206.71%
Operating Profit Margin (ROS)
23.14%
Net Profit Margin
23.29%
Return on Equity (ROE)
65.24%
Quick Ratio
0.78%
Cash Ratio
0.36%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?